RL7_HUMAN - dbPTM
RL7_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RL7_HUMAN
UniProt AC P18124
Protein Name 60S ribosomal protein L7
Gene Name RPL7
Organism Homo sapiens (Human).
Sequence Length 248
Subcellular Localization
Protein Description Component of the large ribosomal subunit. [PubMed: 12962325 Binds to G-rich structures in 28S rRNA and in mRNAs. Plays a regulatory role in the translation apparatus; inhibits cell-free translation of mRNAs.]
Protein Sequence MEGVEEKKKEVPAVPETLKKKRRNFAELKIKRLRKKFAQKMLRKARRKLIYEKAKHYHKEYRQMYRTEIRMARMARKAGNFYVPAEPKLAFVIRIRGINGVSPKVRKVLQLLRLRQIFNGTFVKLNKASINMLRIVEPYIAWGYPNLKSVNELIYKRGYGKINKKRIALTDNALIARSLGKYGIICMEDLIHEIYTVGKRFKEANNFLWPFKLSSPRGGMKKKTTHFVEGGDAGNREDQINRLIRRMN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MEGVEEKK
-------CCCHHHHH
10.2412962325
7Ubiquitination-MEGVEEKKKEVPAV
-CCCHHHHHHCCCCC
56.4933845483
8UbiquitinationMEGVEEKKKEVPAVP
CCCHHHHHHCCCCCC
58.4027667366
9UbiquitinationEGVEEKKKEVPAVPE
CCHHHHHHCCCCCCH
75.0232015554
13UbiquitinationEKKKEVPAVPETLKK
HHHHCCCCCCHHHHH
34.3727667366
15UbiquitinationKKEVPAVPETLKKKR
HHCCCCCCHHHHHHH
30.8422817900
17PhosphorylationEVPAVPETLKKKRRN
CCCCCCHHHHHHHCC
37.5030266825
19AcetylationPAVPETLKKKRRNFA
CCCCHHHHHHHCCHH
64.7623236377
19UbiquitinationPAVPETLKKKRRNFA
CCCCHHHHHHHCCHH
64.7627667366
19SuccinylationPAVPETLKKKRRNFA
CCCCHHHHHHHCCHH
64.7623954790
20UbiquitinationAVPETLKKKRRNFAE
CCCHHHHHHHCCHHH
55.4133845483
21UbiquitinationVPETLKKKRRNFAEL
CCHHHHHHHCCHHHH
55.8123503661
29AcetylationRRNFAELKIKRLRKK
HCCHHHHHHHHHHHH
37.3723236377
29UbiquitinationRRNFAELKIKRLRKK
HCCHHHHHHHHHHHH
37.3723000965
31AcetylationNFAELKIKRLRKKFA
CHHHHHHHHHHHHHH
43.74-
31UbiquitinationNFAELKIKRLRKKFA
CHHHHHHHHHHHHHH
43.7423000965
35UbiquitinationLKIKRLRKKFAQKML
HHHHHHHHHHHHHHH
57.7623000965
36UbiquitinationKIKRLRKKFAQKMLR
HHHHHHHHHHHHHHH
39.2323000965
37UbiquitinationIKRLRKKFAQKMLRK
HHHHHHHHHHHHHHH
11.0523000965
40UbiquitinationLRKKFAQKMLRKARR
HHHHHHHHHHHHHHH
36.1523000965
40AcetylationLRKKFAQKMLRKARR
HHHHHHHHHHHHHHH
36.1525825284
44UbiquitinationFAQKMLRKARRKLIY
HHHHHHHHHHHHHHH
42.1423000965
48UbiquitinationMLRKARRKLIYEKAK
HHHHHHHHHHHHHHH
33.4123000965
48AcetylationMLRKARRKLIYEKAK
HHHHHHHHHHHHHHH
33.4126051181
51PhosphorylationKARRKLIYEKAKHYH
HHHHHHHHHHHHHHH
23.0928152594
53UbiquitinationRRKLIYEKAKHYHKE
HHHHHHHHHHHHHHH
45.8521906983
53AcetylationRRKLIYEKAKHYHKE
HHHHHHHHHHHHHHH
45.8526051181
55UbiquitinationKLIYEKAKHYHKEYR
HHHHHHHHHHHHHHH
56.6233845483
59AcetylationEKAKHYHKEYRQMYR
HHHHHHHHHHHHHHH
49.6426051181
59UbiquitinationEKAKHYHKEYRQMYR
HHHHHHHHHHHHHHH
49.6423503661
64UbiquitinationYHKEYRQMYRTEIRM
HHHHHHHHHHHHHHH
1.4823000965
67UbiquitinationEYRQMYRTEIRMARM
HHHHHHHHHHHHHHH
20.4823000965
77UbiquitinationRMARMARKAGNFYVP
HHHHHHHHCCCEEEC
51.6223000965
82PhosphorylationARKAGNFYVPAEPKL
HHHCCCEEECCCCCE
14.9928152594
84UbiquitinationKAGNFYVPAEPKLAF
HCCCEEECCCCCEEE
21.3723000965
87UbiquitinationNFYVPAEPKLAFVIR
CEEECCCCCEEEEEE
38.7823000965
88UbiquitinationFYVPAEPKLAFVIRI
EEECCCCCEEEEEEE
43.9123000965
88AcetylationFYVPAEPKLAFVIRI
EEECCCCCEEEEEEE
43.9126051181
96MethylationLAFVIRIRGINGVSP
EEEEEEECCCCCCCH
30.04115492247
102PhosphorylationIRGINGVSPKVRKVL
ECCCCCCCHHHHHHH
22.0228985074
104UbiquitinationGINGVSPKVRKVLQL
CCCCCCHHHHHHHHH
47.3623000965
107UbiquitinationGVSPKVRKVLQLLRL
CCCHHHHHHHHHHHH
50.7323000965
108UbiquitinationVSPKVRKVLQLLRLR
CCHHHHHHHHHHHHH
2.6321963094
116UbiquitinationLQLLRLRQIFNGTFV
HHHHHHHHHHCCCEE
49.5723000965
121UbiquitinationLRQIFNGTFVKLNKA
HHHHHCCCEEECCHH
26.7623000965
124AcetylationIFNGTFVKLNKASIN
HHCCCEEECCHHHCC
42.0019608861
124UbiquitinationIFNGTFVKLNKASIN
HHCCCEEECCHHHCC
42.0023000965
124MethylationIFNGTFVKLNKASIN
HHCCCEEECCHHHCC
42.0022647069
127SuccinylationGTFVKLNKASINMLR
CCEEECCHHHCCCHH
54.6821890473
127AcetylationGTFVKLNKASINMLR
CCEEECCHHHCCCHH
54.6825953088
127SuccinylationGTFVKLNKASINMLR
CCEEECCHHHCCCHH
54.68-
127UbiquitinationGTFVKLNKASINMLR
CCEEECCHHHCCCHH
54.6823000965
129PhosphorylationFVKLNKASINMLRIV
EEECCHHHCCCHHHC
18.9927251275
132SulfoxidationLNKASINMLRIVEPY
CCHHHCCCHHHCCCH
2.2521406390
134MethylationKASINMLRIVEPYIA
HHHCCCHHHCCCHHH
21.82115492239
139PhosphorylationMLRIVEPYIAWGYPN
CHHHCCCHHHCCCCC
6.9728152594
141UbiquitinationRIVEPYIAWGYPNLK
HHCCCHHHCCCCCHH
6.4421963094
144PhosphorylationEPYIAWGYPNLKSVN
CCHHHCCCCCHHHHH
4.3528152594
148UbiquitinationAWGYPNLKSVNELIY
HCCCCCHHHHHHHHH
60.0221906983
148MethylationAWGYPNLKSVNELIY
HCCCCCHHHHHHHHH
60.0230793667
149PhosphorylationWGYPNLKSVNELIYK
CCCCCHHHHHHHHHH
33.0821712546
155PhosphorylationKSVNELIYKRGYGKI
HHHHHHHHHCCCCCC
13.7828152594
156UbiquitinationSVNELIYKRGYGKIN
HHHHHHHHCCCCCCC
32.1423000965
156AcetylationSVNELIYKRGYGKIN
HHHHHHHHCCCCCCC
32.1426051181
156MethylationSVNELIYKRGYGKIN
HHHHHHHHCCCCCCC
32.1466702645
159UbiquitinationELIYKRGYGKINKKR
HHHHHCCCCCCCHHH
21.1921963094
159PhosphorylationELIYKRGYGKINKKR
HHHHHCCCCCCCHHH
21.1920068231
161UbiquitinationIYKRGYGKINKKRIA
HHHCCCCCCCHHHEE
34.3223000965
161AcetylationIYKRGYGKINKKRIA
HHHCCCCCCCHHHEE
34.3219608861
162UbiquitinationYKRGYGKINKKRIAL
HHCCCCCCCHHHEEE
8.7421963094
164UbiquitinationRGYGKINKKRIALTD
CCCCCCCHHHEEECC
47.0724816145
170PhosphorylationNKKRIALTDNALIAR
CHHHEEECCCHHHHH
20.4121712546
172UbiquitinationKRIALTDNALIARSL
HHEEECCCHHHHHHH
31.2621890473
181UbiquitinationLIARSLGKYGIICME
HHHHHHHHCEEEEHH
45.6721963094
182PhosphorylationIARSLGKYGIICMED
HHHHHHHCEEEEHHH
16.2626126808
182UbiquitinationIARSLGKYGIICMED
HHHHHHHCEEEEHHH
16.2622505724
183UbiquitinationARSLGKYGIICMEDL
HHHHHHCEEEEHHHH
13.2821963094
195PhosphorylationEDLIHEIYTVGKRFK
HHHHHHHHHHHHHHH
7.7419060867
196PhosphorylationDLIHEIYTVGKRFKE
HHHHHHHHHHHHHHH
28.5726126808
199AcetylationHEIYTVGKRFKEANN
HHHHHHHHHHHHHHC
50.7726051181
199UbiquitinationHEIYTVGKRFKEANN
HHHHHHHHHHHHHHC
50.7721906983
202AcetylationYTVGKRFKEANNFLW
HHHHHHHHHHHCCCC
61.0126051181
202MethylationYTVGKRFKEANNFLW
HHHHHHHHHHHCCCC
61.0142367625
202UbiquitinationYTVGKRFKEANNFLW
HHHHHHHHHHHCCCC
61.0121963094
212UbiquitinationNNFLWPFKLSSPRGG
HCCCCCEECCCCCCC
43.3021963094
212AcetylationNNFLWPFKLSSPRGG
HCCCCCEECCCCCCC
43.3026051181
214PhosphorylationFLWPFKLSSPRGGMK
CCCCEECCCCCCCCC
38.6028450419
215PhosphorylationLWPFKLSSPRGGMKK
CCCEECCCCCCCCCC
29.1128450419
217MethylationPFKLSSPRGGMKKKT
CEECCCCCCCCCCCE
57.13115492255
221UbiquitinationSSPRGGMKKKTTHFV
CCCCCCCCCCEEEEE
55.1624816145
222UbiquitinationSPRGGMKKKTTHFVE
CCCCCCCCCEEEEEC
46.6022505724
223UbiquitinationPRGGMKKKTTHFVEG
CCCCCCCCEEEEECC
53.8121906983
224PhosphorylationRGGMKKKTTHFVEGG
CCCCCCCEEEEECCC
34.0923312004
225PhosphorylationGGMKKKTTHFVEGGD
CCCCCCEEEEECCCC
23.3823312004

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RL7_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RL7_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RL7_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ZNF7_HUMANZNF7physical
9268371
RS3A_HUMANRPS3Aphysical
22939629
RS4X_HUMANRPS4Xphysical
22939629
RS6_HUMANRPS6physical
22939629
RSSA_HUMANRPSAphysical
22939629
RS3_HUMANRPS3physical
22939629
RLA0_HUMANRPLP0physical
22939629
RL9_HUMANRPL9physical
22939629
RS13_HUMANRPS13physical
22939629
RS14_HUMANRPS14physical
22939629
RS15A_HUMANRPS15Aphysical
22939629
RS15_HUMANRPS15physical
22939629
RS16_HUMANRPS16physical
22939629
RS19_HUMANRPS19physical
22939629
RS23_HUMANRPS23physical
22939629
RS26_HUMANRPS26physical
22939629
RS2_HUMANRPS2physical
22939629
RS7_HUMANRPS7physical
22939629
RS8_HUMANRPS8physical
22939629
RS24_HUMANRPS24physical
22939629
RL8_HUMANRPL8physical
22939629
RS11_HUMANRPS11physical
22939629
RS5_HUMANRPS5physical
22939629
RS20_HUMANRPS20physical
22939629
RS12_HUMANRPS12physical
22939629
RS28_HUMANRPS28physical
22939629
RS25_HUMANRPS25physical
22939629
RS21_HUMANRPS21physical
22939629
RS29_HUMANRPS29physical
22939629
RS27L_HUMANRPS27Lphysical
22939629
RRS1_HUMANRRS1physical
22939629
TMX1_HUMANTMX1physical
22939629
IPO5_HUMANIPO5physical
20828572
RAN_HUMANRANphysical
20828572
IL7RA_HUMANIL7Rphysical
23151878
ABCE1_HUMANABCE1physical
26344197
BRX1_HUMANBRIX1physical
26344197
CAPR1_HUMANCAPRIN1physical
26344197
DDX24_HUMANDDX24physical
26344197
EF1A1_HUMANEEF1A1physical
26344197
EIF3C_HUMANEIF3Cphysical
26344197
RACK1_HUMANGNB2L1physical
26344197
GNL1_HUMANGNL1physical
26344197
GNL3_HUMANGNL3physical
26344197
PABP1_HUMANPABPC1physical
26344197
PABP4_HUMANPABPC4physical
26344197
RNPS1_HUMANRNPS1physical
26344197
RL10A_HUMANRPL10Aphysical
26344197
RL12_HUMANRPL12physical
26344197
RL13A_HUMANRPL13Aphysical
26344197
RL14_HUMANRPL14physical
26344197
RL15_HUMANRPL15physical
26344197
RL17_HUMANRPL17physical
26344197
RL23_HUMANRPL23physical
26344197
RL23A_HUMANRPL23Aphysical
26344197
RL27A_HUMANRPL27Aphysical
26344197
RL28_HUMANRPL28physical
26344197
RL3_HUMANRPL3physical
26344197
RL30_HUMANRPL30physical
26344197
RL35_HUMANRPL35physical
26344197
RL35A_HUMANRPL35Aphysical
26344197
RL37A_HUMANRPL37Aphysical
26344197
RL3L_HUMANRPL3Lphysical
26344197
RL5_HUMANRPL5physical
26344197
RL7A_HUMANRPL7Aphysical
26344197
RL8_HUMANRPL8physical
26344197
RL9_HUMANRPL9physical
26344197
RLA1_HUMANRPLP1physical
26344197
RS16_HUMANRPS16physical
26344197
RS18_HUMANRPS18physical
26344197
RS20_HUMANRPS20physical
26344197
RS25_HUMANRPS25physical
26344197
RS27_HUMANRPS27physical
26344197
RS3A_HUMANRPS3Aphysical
26344197
RS4X_HUMANRPS4Xphysical
26344197
RS5_HUMANRPS5physical
26344197
RS6_HUMANRPS6physical
26344197
RS7_HUMANRPS7physical
26344197
RSSA_HUMANRPSAphysical
26344197
TBB4B_HUMANTUBB4Bphysical
26344197
WDR12_HUMANWDR12physical
26344197
CBX2_HUMANCBX2physical
28514442
SRS12_HUMANSRSF12physical
28514442
BMI1_HUMANBMI1physical
28514442
RL26L_HUMANRPL26L1physical
28514442
PHC2_HUMANPHC2physical
28514442
ZN689_HUMANZNF689physical
28514442
TSYL2_HUMANTSPYL2physical
28514442
RL36L_HUMANRPL36ALphysical
28514442
NOC4L_HUMANNOC4Lphysical
28514442
DCAF1_HUMANVPRBPphysical
28514442
GZF1_HUMANGZF1physical
28514442
RRP12_HUMANRRP12physical
28514442
ZBT11_HUMANZBTB11physical
28514442
NGRN_HUMANNGRNphysical
28514442
RBM19_HUMANRBM19physical
28514442
ZBT24_HUMANZBTB24physical
28514442
KRR1_HUMANKRR1physical
28514442
ZN771_HUMANZNF771physical
28514442
UTP23_HUMANUTP23physical
28514442
ZCCHV_HUMANZC3HAV1physical
28514442
ZN668_HUMANZNF668physical
28514442
ZN184_HUMANZNF184physical
28514442
RM13_HUMANMRPL13physical
28514442
RM27_HUMANMRPL27physical
28514442
POP1_HUMANPOP1physical
28514442
RL26_HUMANRPL26physical
28514442
RALY_HUMANRALYphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RL7_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
"Characterization and analysis of posttranslational modifications ofthe human large cytoplasmic ribosomal subunit proteins by massspectrometry and Edman sequencing.";
Odintsova T.I., Muller E.C., Ivanov A.V., Egorov T.A., Bienert R.,Vladimirov S.N., Kostka S., Otto A., Wittmann-Liebold B.,Karpova G.G.;
J. Protein Chem. 22:249-258(2003).
Cited for: MASS SPECTROMETRY, AND PROBABLE ACETYLATION AT MET-1.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-29; LYS-31; LYS-124 ANDLYS-161, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-139 AND TYR-195, ANDMASS SPECTROMETRY.

TOP